Elbit Imaging Ltd. (NASDAQ: EMITF) (”Elbit” “Company”) that its subsidiary, InSightec Ltd., announced that Japan’s Ministry of Health, Labor and Welfare (MHLW) has approved the company’s ExAblate(R) MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with uterine fibroids.

Thanks to medical imaging techniques such as X-ray CT, ultrasound imaging and MRI, doctors have long been able to see to varying degrees what’s going on inside a patient’s body, and now a Texas A&M University mathematician is trying to find new and better ways to do so.

Most Americans have never heard of magnetic resonance guided focused ultrasound (MRgFUS), yet it is a technology that promises to revolutionize medical care around the world.
“We’re at the same point with focused ultrasound as we were with diagnostic MRIs several decades ago,” says Neal F. Kassell, M.D., a professor of neurosurgery at the University of [...]

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, announces new data regarding the use of DEFINITY® Vial For (Perflutren Lipid Microsphere) Injectable Suspension. A large, retrospective study (abstract number 1027-265) presented by Dr. Michael Main at the 58th Annual Scientific Sessions of the American College of Cardiology held in Orlando, Florida, demonstrated that [...]

Combining transcranial Doppler (TCD) ultrasound with microspheres and the clot busting drug tissue plasminogen activator (tPA) is more effective than tPA alone in treating patients suffering from ischemic stroke, according to results from a Phase I/II investigational clinical study presented at the American Stroke Association’s International Stroke Conference 2009.